PRELONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prelone, and what generic alternatives are available?
Prelone is a drug marketed by Teva and Muro and is included in two NDAs.
The generic ingredient in PRELONE is prednisolone. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the prednisolone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prelone
A generic version of PRELONE was approved as prednisolone by ZHEJIANG XIANJU on May 2nd, 2024.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRELONE?
- What are the global sales for PRELONE?
- What is Average Wholesale Price for PRELONE?
Summary for PRELONE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Clinical Trials: | 13 |
| Patent Applications: | 7,537 |
| DailyMed Link: | PRELONE at DailyMed |
Recent Clinical Trials for PRELONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 2 |
| Children's Oncology Group | Phase 1/Phase 2 |
| National Cancer Institute (NCI) | Phase 1/Phase 2 |
US Patents and Regulatory Information for PRELONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | PRELONE | prednisolone | SOLUTION;ORAL | 089081-001 | Feb 4, 1986 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Muro | PRELONE | prednisolone | SYRUP;ORAL | 089654-001 | Jan 17, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for PRELONE
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| LE VET B.V. | Equisolon | Prednisolone | EMEA/V/C/002382Alleviation of inflammatory and clinical parameters associated with recurrent airway obstruction (RAO) in horses, in combination with environmental control. | Authorised | no | no | no | 2014-03-12 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
